Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Enzymes in DNA synthesis" encompass a group of proteins required for the accurate and efficient replication and repair of DNA. Major enzyme classes include DNA polymerases (responsible for synthesizing new DNA strands), helicases (unwinding the double helix), primases (synthesizing short RNA primers), ligases (joining DNA fragments), topoisomerases (relieving torsional stress), and nucleases (removing nucleotides or processing DNA ends)[5][7][9]. These enzymes are critical for cell proliferation and genome integrity and are frequent targets in cancer chemotherapy and antiviral therapy, largely through inhibition of DNA polymerases or synthesis of nucleotides[2][3][5]. Because this term covers numerous distinct proteins belonging to different molecular families, it is overly broad for use as a canonical drug target[1][3][5]. To retrieve structured information for a specific target, such as "DNA polymerase delta," "Thymidylate synthase," or "Topoisomerase II alpha," use the precise full name of the enzyme.
Inhibition of DNA polymerase activity; Incorporation of chain-terminating analogs; Inhibition of nucleotide synthesis
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enzymes in DNA synthesis.